- Home
- DERM vs ANTA Comparison
DERM vs ANTA Comparison
Compare DERM & ANTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DERM | ANTA |
|---|---|---|
| Founded | 2014 | 2022 |
| Country | United States | Singapore |
| Employees | N/A | 113 |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.9M | 182.1M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | DERM | ANTA |
|---|---|---|
| Price | $7.11 | $5.23 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $12.67 | ★ $16.17 |
| AVG Volume (30 Days) | ★ 338.9K | 1.9K |
| Earning Date | 05-13-2026 | 06-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 34.72 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $61,858,000.00 | N/A |
| Revenue This Year | $39.72 | $21.95 |
| Revenue Next Year | $63.24 | $30.46 |
| P/E Ratio | ★ N/A | $19.77 |
| Revenue Growth | ★ 10.20 | N/A |
| 52 Week Low | $4.31 | $4.71 |
| 52 Week High | $9.56 | $13.82 |
Technical Indicators
Market Signals| Indicator | DERM | ANTA |
|---|---|---|
| Relative Strength Index (RSI) | 63.54 | 33.47 |
| Support Level | $7.00 | N/A |
| Resistance Level | $7.69 | $9.81 |
| Average True Range (ATR) | 0.44 | 0.43 |
| MACD | 0.06 | -0.08 |
| Stochastic Oscillator | 86.21 | 21.09 |
Price Performance
Historical ComparisonAbout DERM Journey Medical Corporation
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.
About ANTA Antalpha Platform Holding Company Ordinary Shares
Antalpha Platform Holding Co provides financing, technology and risk management solutions to institutional and corporate customers in the crypto asset industry. The company operates through Antalpha Prime platform in the following areas: Supply chain financing and Technology and services. Its revenue prominently consists of technology financing fees charged on the supply chain loans.